Related Experiment Video
Updated: Nov 23, 2025

Deacetylation Assays to Unravel the Interplay between Sirtuins SIRT2 and Specific Protein-substrates
Published on: February 27, 2016
Deacetylation-activated construction of single quantum dot-based nanosensor for sirtuin 1 assay
Juan Hu1, Li-Yuan Pan1, Yueying Li1
1College of Chemistry, Chemical Engineering and Materials Science, Collaborative Innovation Center of Functionalized Probes for Chemical Imaging in Universities of Shandong, Key Laboratory of Molecular and Nano Probes, Ministry of Education, Shandong Provincial Key Laboratory of Clean Production of Fine Chemicals, Shandong Normal University, Jinan, 250014, China.
Researchers developed a novel single quantum dot (QD)-based nanosensor for detecting Sirtuin 1 (SIRT1) activity. This sensitive assay enables precise measurement of enzyme kinetics and inhibitor screening, advancing epigenetic research and drug discovery.
Area of Science:
- Biochemistry
- Molecular Biology
- Nanotechnology
Background:
- Sirtuin 1 (SIRT1) is a key histone deacetylase regulating crucial biological processes.
- Dysregulation of SIRT1 is implicated in diseases like cancer, diabetes, and aging.
- Accurate detection of SIRT1 activity is vital for therapeutic development.
Purpose of the Study:
- To develop a deacetylation-activated single quantum dot (QD)-based nanosensor for sensitive SIRT1 activity detection.
- To establish a platform for enzyme kinetics measurement and SIRT1 inhibitor screening.
- To enable detection of SIRT1 activity in cancer cells for epigenetic research.
Main Methods:
- Constructed a nanosensor using a Cy5-labeled peptide substrate and a streptavidin-coated QD.
- Utilized SIRT1's deacetylase activity to trigger peptide biotinylation and QD-peptide assembly via FRET.
- Employed total internal reflection fluorescence-based single-molecule detection for quantification.
Main Results:
- Achieved a highly sensitive SIRT1 detection limit as low as 3.91 pM.
- Demonstrated the nanosensor's capability for enzyme kinetic parameter measurement.
- Successfully applied the nanosensor to detect SIRT1 activity in cancer cells.
Conclusions:
- The developed QD-based nanosensor offers a sensitive and robust method for SIRT1 activity assay.
- This platform facilitates SIRT1 inhibitor screening and drug discovery.
- The nanosensor provides a powerful tool for epigenetic research and understanding SIRT1's role in disease.
More Related Videos
07:13Author Spotlight: High-Quality Quantum Dot Nanobeads for Sensitive Fluorescent Lateral Flow Immunoassays
Published on: June 28, 2024
10:43Author Spotlight: Single-Molecule Surface-Enhanced Raman Scattering Measurements Enabled by Plasmonic DNA Origami Nanoantennas
Published on: July 21, 2023